WuXi Biologics (2269.HK), a global leading Contract Research, Development and Manufacturing Organization (CRDMO), and ...
A plain-talk shelf-life strategy for US retailers to reduce shrink, protect gross margin, and improve sell-through without relying on deep discounting.
HanchorBio, Inc. (TPEx: 7827), a global clinical-stage biotechnology company advancing next-generation immunotherapies for ...
How Ropack’s evolution from service provider to strategic CMO partner reflects broader shifts in manufacturing, packaging, ...
Strategic decision making is never static. It is a living process that should always stay rooted in curiosity, humility and ...
Daily Times on MSNOpinion
Specious Invocation of the Monroe DoctrinePublished on: January 22, 2026 6:40 AM
Pakistan, Jan. 22 -- "Look there, Sancho Panza, where thirty or forty hulking giants appear, whom I intend to do battle with ...
HONG KONG, HONG KONG , HONG KONG, January 21, 2026 /EINPresswire.com/ -- As skincare science rapidly evolves toward ...
Lagos Chamber of Commerce urges coordinated AI strategy, stronger infrastructure and regulation to position Nigeria as regional artificial intelligence hub.
A CDMO championing a commitment to patients may sound like lip service or branding, but truly patient-centric CDMOs offer ...
News-Medical.Net on MSN
JPM highlights | WuXi Biologics CEO Dr. Chris Chen: Scaled CRDMO platform delivering sustainable high growth
On January 14, Dr. Chris Chen, CEO of WuXi Biologics, delivered a keynote at the 44th J.P. Morgan Healthcare Conference, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results